Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.
Lancet
; 383(9916): 515-23, 2014 Feb 08.
Article
en En
| MEDLINE
| ID: mdl-24209977
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Antivirales
/
Inhibidores de Proteasas
/
Ribavirina
/
Uridina Monofosfato
/
Proteínas no Estructurales Virales
/
Hepatitis C Crónica
Tipo de estudio:
Clinical_trials
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2014
Tipo del documento:
Article